slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,580
Current window 22,051-22,080
Pages 3,986
Rows per page 30
Component
22,051-22,080 of 119,580
27
The slide uses a comparative analysis of pricing and regulatory status to undermine the competitor's market position.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
30
The slide uses a 'villain' narrative style to attack the legitimacy of Harmony Biosciences' IP.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
31
The slide argues that the patent claims are spurious because the inventors are the same as those who published the molecule in 2002, and PubChem shows prior art from 2006.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
33
The slide uses a 'before-after' style comparison of a website vs. an empty search result to discredit the subject.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
36
The slide uses visual evidence (empty chair, press conference) to frame the subject as a villain in a political/regulatory context.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
60
The slide uses visual evidence to link a specific chemical moiety (piperidine) to a known safety liability (hERG blockade).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
63
The slide uses a screenshot of a blog post with red underlines to emphasize key quotes about hERG activity and piperidine.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
151
Uses anecdotal evidence from Facebook patient support groups to highlight a safety gap.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
240
The slide uses ClinicalTrials.gov record history to demonstrate a 'red flag' in trial reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
296
The slide uses screenshots of two different websites to demonstrate consistent messaging across patient and HCP channels.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
11
The slide uses a 'villain' framing by calling IonQ a scam and quantum computing a 'science fiction fantasy'.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology2 hits
43
The slide uses screenshots of official cloud provider documentation to invalidate the company's public claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
47
The slide uses screenshots of two different IonQ presentations to demonstrate the removal of the 2020 milestone.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
50
The slide uses a 'before-after' style comparison of evidence availability to highlight a discrepancy in technical disclosure.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
63
Uses red boxes to highlight marketing imagery and an arrow to point to the actual enclosure.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
68
Uses a 'before-after' style contradiction between company marketing and reality.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
72
Uses direct quotes and screenshots from UMD and L3-Harris websites to establish the contradiction.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
117
The slide aims to validate or challenge IonQ's performance claims through independent expert testing.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg2 hits
164
The slide uses red circles to highlight the 'gold-colored' chip in both real-world photos and marketing diagrams to suggest a misleading presentation.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
181
The slide uses visual callouts (red circles and arrows) to point out the specific text segments being compared.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
32
The slide explains the technical foundation of the company's core business by detailing the photolithography process.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products2 hits
35
The slide uses a technical diagram and a 3D render to explain the reflective nature of EUV masks.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products2 hits
38
The slide explains the 'Actinic' technology advantage and provides unit pricing for four different inspection systems.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products2 hits
42
The slide uses a 'villain critique' approach to undermine the target company's reputation by highlighting failed R&D and reliance on third-party components.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products2 hits
54
The slide uses a 'before-after' comparison of product generations to undermine the company's technological narrative.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's productsLoop · The Reveal2 hits
139
The slide uses a Q&A format with a former KLA executive to highlight technical failures (particle generation) and high costs of the Sumitomo product.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 2 hits
143
Uses visual evidence (product photos) to prove a rebranding deception.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Conclusion and call to action2 hits
144
The slide includes a red circle highlighting the 'In-house' claim, which the activist deck author is refuting.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Conclusion and call to action2 hits
145
The slide uses historical evidence (2013 presentation, 2016 paper) to debunk a claim of innovation.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Conclusion and call to action2 hits
147
The slide uses a side-by-side comparison of a patent document and a marketing brochure to expose a contradiction in product originality.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Conclusion and call to action2 hits